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ABSTRACT 
Preterm birth is a major determinant of neonatal mortality and morbidity worldwide. One 
of the main causes of preterm parturition is maternal infection Dissemination of 
microorganisms from the vagina and cervix via the ascending route is the preponderant 
way of infection, although microorganisms may also access the amniotic cavity and the 
fetus via other pathways. 
The pathophysiological processes that are set in motion during maternal infection lead to 
preterm labor and fetal damage with severe consequences both for the mother as well as 
the offspring. During inflammation associated to infection, a plethora of pro-inflammatory 
agents are produced in high levels. Thus, prostaglandins are released simultaneously with 
nitric oxide and their overproduction promotes uterine contractions contributing to 
embryonic and fetal expulsion. Oxygen and nitrogen reactive species and pro-
inflammatory cytokines have been associated with preterm birth as well as fetal damage 
and they might contribute to the high mortality and morbidity associated with preterm 
labor. 
The study of these pathophysiological processes is necessary to develop better tocolytic 
agents. Therefore, it is essential to establish good animal models of infection-induced 
preterm labor that would mimic the human parturition biology.  
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Preterm birth is defined as childbirth occurring before week 37 of gestation is completed 
and is a major determinant of neonatal mortality and morbidity worldwide [1]. According 
to the World Health Organization (WHO), an estimated 15 million babies are born 
prematurely every year. Preterm birth (PTB) affects mainly Sub-Saharan Africa and South 
Asia, accounting for over 60% of the cases worldwide. In Latin America and the Caribbean 
region, PTB occurs in 8.1% of all pregnancies [2]. This is not, however, a problem only of 
the low- to middle-income countries, since it has been documented an increase in PTB 
rates over the past 20 years in industrialized countries [2].  
Preterm birth may result from either spontaneous developments or medically indicated 
interventions. Known causes of spontaneous preterm labor include infection (intrauterine 
or extrauterine), multiple gestation, placental abruption, hormonal disruptions and other 
factors, though a large proportion of preterm births are ‘idiopathic’, or without known 
cause [3]. 
The risk of death of a premature newborn is 120 times folds higher that of a baby born at 
term [4]. Excluding congenital malformations, premature birth accounts for approximately 
70% of all neonatal deaths and results in nearly 50 percent of long-term neurological 
problems [5]. Sequelae of preterm birth are common in the neonatal period, may persist 
into adulthood and are inversely related to gestational age. Preterm babies are at risk of 
short-term morbidity due to various causes (diseases of the respiratory syndrome, 
intraventricular hemorrhage, necrotizing enterocolitis, sepsis, retinopathy of prematurity) 
and long term morbidity, for conditions such as cerebral palsy, learning disabilities, 
blindness and respiratory diseases [6].  
Maternal intrauterine inflammation has been strongly associated with preterm parturition 
[7]. Intrauterine inflammation/infection leads to a systemic inflammatory condition in the 
fetus called fetal inflammatory response syndrome (FIRS), characterized by an increase in 
pro-inflammatory cytokine levels [8] with maternal infection accounting for at least 25-
40% of spontaneous PTB [3]. Intrauterine inflammation associated with premature birth, 
premature rupture of fetal membranes or placental inflammation has been linked to adverse 
neurological outcomes for ex-preterm children; like periventricular leukomalacia or 
cerebral palsy [9] as well as with other neuropsychiatric conditions such as cognitive 
dysfunction and behavioral deficits, schizophrenia and even autism [10-12]. However, it 
remains unclear whether these adverse neonatal outcomes are due to preterm birth or to 
prenatal inflammation. 
Although survival rates of premature babies have improved in the last decades, the rates of 
morbidity are still high. Approximately 90% of infants born before week 30 of gestation 
show abnormalities in brain magnetic resonance which might be translated later in life in 
adverse cognitive and behavioral outcomes. Moreover, the risk of cerebral palsy is 70 
times higher in these newborns than those born at term [13]. In addition to this enormous 
waste of human potential, the monetary cost is estimated at tens of billions of dollars 
annually, including the impact of neonatal intensive care, long-term cost recovery, 





educational programs, special social assistance, institutional care and other services for 
survivors with disabilities and their families. 
Parturition is the process involving changes in gestational tissues that results in birth as 
well as the events in the maternal, placental and fetal compartments that lead to these 
changes. The precise biomolecular mechanisms, by which human parturition is initiated 
spontaneously, either at term or preterm, are not well understood. 
The current therapeutic approaches are directed toward stopping premature labor when it is 
started and they have generally been unsuccessful. 
A better understanding of the mechanisms that regulate the onset of labor may enable the 
development of new strategies for early diagnosis, treatment or even prevention of preterm 




Maternal immune system and pregnancy 
 
 
Mammalian pregnancy represents a singular challenge for the maternal immune system: it 
must ensure tolerance to accept the semi-allogeneic embryo while maintaining immune 
reactivity against potential infections in order to protect both the mother and the fetus [14]. 
Several changes take place at the feto-maternal interface, particularly a shift in cytokine 
pattern. Pregnancy has been associated with a Th2 phenomenon. This shift from type 1 to 
type 2 cytokine production during pregnancy is necessary since type 1 cytokines (e.g. IL-
1β, IFN-γ and TNF-α) are potentially harmful because they inhibit embryonic and fetal 
development [36]. 
Interestingly, it has been shown that the innate immune system is activated during 
pregnancy.  
In spite of the mechanisms present in the feto-maternal interface to prevent infection, some 
microorganisms are able to breach the placental barrier and/or reach the amniotic cavity 
leading to an intense inflammatory response in the fetus (FIRS) which has been associated 
with PTB [3, 8, 14].  
Bacterial infections of pregnant women, fetus and newborn represent major problems in 
obstetric and perinatal care. Maternal infection is strongly related to the loss of pregnancy, 
including fetal abnormalities, stillbirth, premature labor, premature rupture of membranes 
and miscarriage. Infectious agents can reach the feto-placental compartment via five 
different pathways (Figure 1): 1) ascending from the vagina and the cervix; 2) 
hematogenous dissemination through the placenta (transplacental infection); 3) retrograde 
seeding from the peritoneal cavity through the fallopian tubes; and 4) accidental 
introduction at the time of invasive procedures such as amniocentesis, percutaneous fetal 
blood sampling, chorionic villous sampling, or shunting; 5) contaminated food or mouth 
infections [15]. The most frequently way of microorganisms to access the uterus is 
ascending from the vagina and cervix. Ascending infections extends to the choriodecidual 
space and may ultimately invade the membranes, amniotic fluid, and fetus [12].  









Figure 1. Pathways via which infectious agents can reach the feto-placental compartment: I) ascending from 
the vagina and the cervix; II) retrograde seeding from the peritoneal cavity through the fallopian tubes; III) 
hematogenous dissemination through the placenta (transplacental infection); IV) accidental introduction at 
the time of invasive procedures such as amniocentesis, percutaneous fetal blood sampling, chorionic villous 














Several studies support the notion that bacterial vaginosis, the abnormal bacterial 
colonization of the vagina, is strongly associated with preterm delivery. Due to an 
interruption in normal vaginal flora, there is an imbalance in the normal vaginal flora, with 
a reduction in lactobacillus and an overgrowth of other anaerobic bacteria such as 
gardenerella, bacteroides, and mobiluncus, all vaginal organisms of relatively low 
virulence [16]. 
After changes in vaginal and/or cervix flora, microorganisms ascend into the 
choriodecidual space. From there, microorganisms are able to migrate between the chorion 
and amnion and infect the intrauterine cavity with some of the fetuses ultimately becoming 
infected. However, only a small number of the preterm-delivered fetuses have positive 
blood or cerebrospinal fluid cultures at delivery, being this condition the most advanced 
and serious stage of ascending intrauterine infection [3]. 
As mentioned earlier, prenatal infection and inflammation are the main causes of preterm 
labor and constitute a risk factor for the later development of cerebral palsy and neonatal 
sepsis [17]. Exposure to lipopolysaccharide (LPS) has been associated with a variety of 
lesions in the white matter of the developing brain of the newborn [18], such as 
periventricular leukomalacia, a condition associated with the development of cerebral 
palsy, and diffuse lesions in the white matter, the most common brain abnormality 
associated with adverse neurological development [19]. Even the exposure to low doses of 
LPS, insufficient to induce parturition, has been shown to induce white matter damage in 
the developing brain, with adverse long-term outcomes [9]. 
 
 
Maternal innate immune system activation and premature cervical remodeling 
 
 
Once microorganisms have colonized cervical, uterine and/or amniotic structures, several 
signaling pathways are initiated, which can either individually or collectively promote 
preterm parturition. First, bacteria or even bacterial by-products, such as LPS, are detected 
by immune system pattern recognition receptors, specifically the toll-like receptors (TLRs) 
[20].  
Uterus, cervix, amniotic epithelium, and the decidua abundantly express TLRs, in 
particular TLR-2 and TLR-4 [14] (Figure 2). When TLRs detects bacteria or bacteria 
products, they activate several immune pathways, triggering an inflammatory response 
mediated primarily by pro-inflammatory cytokines such as interleukin-1β (IL-1β), tumor 
necrosis factor alpha (TNF-α) and IL-6, prostaglandins and nitric oxide (NO).  













LPS-induced production of NO has been associated with increased uterine prostaglandin 
(PG) synthesis in a murine model of preterm labor [21]. Interestingly, NO production was 
found to have a dual effect on PG synthesis, with low concentrations of NO 
downregulating PG synthesis and higher concentrations increasing PG levels [21]. The 
secretion of pro-inflammatory cytokines, such as IL-1β and TNF-α, by gestational tissues 
in response to bacterial products has been associated with the pathological process of 
infection-induced rupture of fetal membranes [22]. Moreover, these cytokines may 
stimulate the biosynthesis of IL-6 by decidual cells, which is considered a responsive 
indicator of intrauterine infection in pregnant women [23].  
The	 increased	 expression	 of	 pro-inflammatory	 cytokines	 induces	 the	 augmentation	 of	
matrix	metalloproteinases	(MMP)	production	[24].	These	changes	contribute	to	increased	
enzymatic	 degradation	 of	 the	 extracellular	 matrix	 within	 the	 uterine	 cervix	 [25]. 





Furthermore, IL-1β and TNFα have been	also	shown	to	upregulate	cyclooxygenase	(COX)-
2	activity,	therefore	increasing	PGE2	production	and	promoting	cervical	maturation	[26].	
	Considering that many cell types synthesize the inflammatory mediators, it becomes 
difficult to identify precisely their origin during preterm labor. It has been suggested that  
the infiltration of leukocytes such as neutrophils, macrophages, monocytes, and T and B 
lymphocytes to the choriodecidual tissue immediately before the initiation of labor is 
associated with increased the levels of cytokines IL-1β, IL-6, IL-8, and TNFα, leading to 
the establishment of the inflammatory microenvironment during parturition [27]. 
All these molecules acting in concert induce a complex response involving uterine 
contractions, placental detachment, infiltration of inflammatory cells into gestational 
tissues, a series of biochemical and structural changes in the cervix known as ‘ripening’ 
and weakening of the fetal membranes. Cervical remodeling can be considered as a 
continuous process divided in four overlapping phases: softening, ripening, dilation and 
labor and pospartum repair [28]. Cervical integrity and the correct timing of cervical 
remodeling are essential for maintaining pregnancy. It has been shown that pro-
inflammatory cytokines disrupt the cervical epithelial barrier, thus inducing an earlier 
cervical remodeling that eventually leads to preterm birth [29]. Thus, it has been suggested 
that measurement of fetal fibronectin (as a parameter of membrane degradation) and 
surfactant protein-D (as measurement of intrauterine inflammation) could be used a 
potential markers of greater risk of preterm birth [30].  
Hösli et al. [31] have recently reviewed the use of tocolysis to prevent preterm labor. 
According to these researchers, calcium antagonists and oxytocin receptor antagonists 
seem to have a better neonatal outcome than beta-sympathomimetics with yet not enough 
data regarding the potential usefulness of prostaglandin synthesis inhibitors and nitric 
oxide donor drugs as tocolytic agents [31]. An ideal tocolytic agent should prevent preterm 
birth; improve neonatal outcome with few or non maternal, fetal and neonatal side effects 
and without any long-term side effects [32]. Therefore, an ideal tocolytic agent should be 
able to modulate maternal innate immunity without suppressing it. Intriguingly, neither 
vaginal progesterone nor 17 α-hydroxyprogesterone caproate, two regularly used drugs to 
prevent preterm birth in high-risk populations, have been shown unable to upregulate 
mucosal immunity, collagen content or the number of immune cells in the cervix of treated 
mice, suggesting that these compounds prevent preterm birth by different and still 
unknown mechanisms [33]. Paradoxically, it has been recently shown that blocking IL-1 
receptors might prevent fetal brain damage but not preterm parturition [34], suggesting that 
the mechanisms governing preterm labor are still not fully understood. A recent work by 
Domínguez-Rubio et al. [35] has shown that treatment with melatonin prevented preterm 
parturition in 50% of the cases in an LPS-induced murine model of preterm labor. 
Interestingly, melatonin treatment not only reduced TNFα, prostaglandin E2 and 
prostaglandin F2α levels, decreased COX-2 and iNOS protein expression and NOS activity 
but also protected the fetuses from LPS-induced damage even in the cases in which 
preterm labor was not prevented [35]. Therefore, there is still much to learn about the 
molecular mechanisms involved in inflammation-induced preterm labor in order to design 
the ideal tocolytic agent.  
 






Maternal inflammation and the developing brain 
 
 
Several studies have shown that maternal exposition to LPS during late gestational stages 
lead to fetal death, growth restriction and preterm birth [19]. The central nervous system 
development is a fine tuned process in which each brain area develops at its own pace. 
Therefore, any perturbation at a given point will result in a functional deficit of a certain 
brain area with a concomitant development of a neuropsychiatric disorder later on in life. 
Thus, maternal infections during the second trimester have been suggested to alter the 
migration of post-mitotic neurons from the subventricular zone to the neocortex [36]. Both 
the inflammation-induced neuronal damage as well as the interference on the normal 
pattern of migration of the newly born neurons led to an aberrant cortical development 
[36]. In a similar fashion, it has been reported that maternal administration of LPS induces 
alteration in the developing brain cytoarchitecture of mice [37] and rabbits [38]. The 
increased expression of pro-inflammatory cytokines is critical during this developmental 
stage since it could provoke not only alterations in the cerebral cytoarchitecture, but 
damage in mature oligodendrocyte subpopulations (which are extremely sensitive to 
injuries) and activation of white matter ameboid microglia, thus propagating and 
perpetuating the inflammatory process [37, 38]. The perpetuation of the inflammatory 
response contributes to the brain damage observed in leukomalacia and affects behavioral 
and cognitive capacities later on in life. Meyer et al. [11] reported that maternal immune 
challenge exerts different effects on the fetal brain depending on the gestational stage of 
the pregnancy. Thus, maternal immune stress during midterm pregnancy led to an 
offspring with lesser exploratory activity; whereas a maternal immune challenge during 
late pregnancy was associated altered behavioral patterns related to schizophrenia, autistic 
spectrum disorders, obsessive-compulsive disorders and addictive behavior [11].  
Local intrauterine inflammation is responsible for an overexpression of pro-inflammatory 
cytokines that causes significant fetal brain injury including reactive gliosis, loss of 
different subpopulations of olygodentrocytes and neuronal damage [8, 9]. Similarly, 
Sharangpani et al. [39] have reported an increased caspase activity and a higher number of 
apoptotic bodies in the fetal brain of rats exposed to an intrauterine inflammation model. In 
this model, the authors also showed a secondary damage in the white matter produced by 
the overexpression of cytokines and other pro-inflammatory factors by activated resident 
astrocytes and microglia, contributing to worsen the initial damage [39]. 
The molecular events that take place at the feto-maternal interface after LPS stimulation 
are not fully understood, but it has been shown that the excessive production of oxygen and 
nitrogen reactive species (reviewed in [40]) as well as the presence in the amniotic fluid of 
high levels of pro-inflammatory cytokines, such as TNFα, IL-1β or IL-6 are associated 
with higher risks of developing leukomalacia or cerebral palsy [41]. In this sense, Leitner 
et al. [34] have recently shown that blocking IL-1 receptor prevented fetal cortical brain 
injury but not preterm birth. As mentioned earlier, this intrauterine inflammation 
associated to preterm birth, placental inflammation or premature rupture of the fetal 
membranes can trigger a generalized inflammatory response in the fetus, known as Fetal 





Inflammatory Response Syndrome or FIRS. FIRS has been associated with the 
development of periventricular leukomalacia in premature newborns which leads to motor 
and cognitive deficits in these children (reviewed in [19]). Moreover, it has been described 
the presence of hypertrophic astrocytes and activated microglia, considered markers of 
white matter damage, in the autopsies of premature newborns. 
The neuroinflammatory events that initiate during fetal development could continue during 
the extrauterine life, as suggested by observation of necropsies of patients suffering from 
periventricular leukomalacia and austistic spectrum disorders [42]. This constant 
microglial activation perpetuates the damage by a series of mechanisms: continuous 
production of pro-inflammatory cytokines, cytotoxic metabolites such as glutamate and 
quinolinic acid (which are cytotoxic to olygodendrocytes), oxygen and nitrogen reactive 
species and arachidonic acid derivatives (reviewed in [19]). Since olygodendrocytes 
exhibit low tolerance to oxidative stress and they express calcium-permeable glutamate 
receptors, these cells are extremely susceptible to neuroinflammatory processes. Damaged 
olygodendrocytes are the main source of deposits of myelin and aberrant proteins which 
contribute to neuroinflammation and cognitive deficits observed in periventricular 
leukomalacia and cerebral palsy patients [19]. Similarly, intrauterine inflammation can 
affect the developing brain by other mechanisms such as cerebral hypoperfusion, which 
leads to a hypoxic-ischemic damage and the production of pro-inflammatory cytokines 
[43]. All these mechanisms contribute to development of periventricular leukomalacia 
which is characterized by multiple and small foci of necrosis.  
As shown by Elovitz et al. [9], even lower levels of intrauterine inflammation, which do 
not induce parturition, are still able to produce fetal and neonatal brain damage. Several 
epidemiological studies have found a strong correlation between maternal infection during 
mid and late-term pregnancy and a higher risk for the offspring to suffer from 
schizophrenia or autistic spectrum disorders [42]. In this sense, preclinical studies using 
LPS as a model of bacterial infection or Poli I:C as a model of viral infection have been 
consistent in showing an association between maternal infection and development of mood 
disorders in the offspring. Thus, Lin et al. [44] reported that LPS-treated rats during 
midterm pregnancy induced in the offspring the development of anxiety disorders and an 
elevated response to stress in adulthood. In the same line, Hao et al., [45] found that 
maternal treatment with LPS produced an offspring with delayed cognitive maturity, 
altered hippocampal with augmented astrogliosis and reactive microglia. Similar studies 
have determined that maternal administration of LPS produced behavioral changes such as 
higher levels of anxiety and lower levels of social interaction [46], altered response to pre-
pulse inhibition test [47], object recognition memory [48] and spatial memory [49] in adult 
mice. In fact, many of this deficits and disorders can be detected very early on, as shown 
by Baharnoori et al. [50], who have reported alterations in the neonatal behavior of the 
offspring of rats treated with LPS. These pups showed altered nest-searching behavior, 
olfactory memory and a lower ultrasonic vocalization [50]. These findings provide strong 
evidence that maternal inflammation induces important modifications in the normal 
nervous system development of their offspring and that these pathological changes can be 
detected as behavioral alterations very early on in life. 
 








Preterm birth is a serious health issue with heterogeneous precipitating events that affects 
worldwide. Maternal infection is one of main causes of preterm labor with serious sequelae 
in the newborn and long-term disabilities in the adulthood of ex-preterm infants.  
During inflammation associated to infection, the maternal immune system is over-activated 
and a large number of pro-inflammatory mediators are produced. Pro-inflammatory 
cytokines are expressed in high levels and they have been shown to damage the fetus and 
to be toxic for the normal nervous system development. Prostaglandins are released 
simultaneously with NO and their overproduction promotes uterine contractions 
contributing to embryonic and fetal expulsion. NO and other oxygen and nitrogen reactive 
species also contribute to the onset of preterm labor as well as fetal damage. Collectively, 
these pro-inflammatory mediators contribute to the high mortality and morbidity associated 
with preterm labor. 
The search of better tocolytic agents should be a priority in preterm labor research, 
particularly ones that would not only prevent preterm parturition but would also protect the 
fetus. Therefore, it is essential to develop good animal models that would mimic human 
parturition biology, despite their limitations, in order to answer specific questions related to 
prematurity and to describe the pathophysiological events associated with preterm birth 
that will contribute to the development of rational and efficacious treatment and prevention 
strategies for preterm birth.  
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